- Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)2013 | First Faculty of Medicine
- Deltoid administration of Long-Acting Injectable Risperidone: new possibility for patient to make his own choice2011 | Publication without faculty affiliation
- Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries.2010 | Faculty of Medicine in Hradec Králové
- Risperidone long-acting injectable significantly improved efficacy and tolerability in patients with psychotic disorders previously receiving conventional oral neuroleptcsPublication without faculty affiliation
- Efficacy of risperidone longterm acting injections (Risperidal Consta) in the treatment of schizophrenia and schizoaffective disorders: 2-year results of the e-STAR in the Czech and Slovac Republic2011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- E-STAR - electronic register of schizophrenia patients treated with Risperdal Consta in the Czech and Slovak Republic - 18 months results2009 | First Faculty of Medicine
- Risperdal Consta - long-term acting injections in the treatment of schizophrenia and schizoaffective disorders: preliminary 12-month results of the project e-STAR in the Czech and Slovak Republics2008 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové